SERM's are used as add-back therapy concurrently with GnRH agonist to: (A) Increase shrinkage of leiomyoma, (B) Prevent bone loss, (C) Avoid vasomotor symptoms, (D) Decrease venous thromboembolism risks
Answer is B. SERMs  are used concurrently with GnRH agonist to prevent bone loss.